MEDICINEWISE UPDATE     NOVEMBER 2018 1. New resources to improve the quality of at-home palliative care service delivery NPS MedicineWise has collaborated with caring@home to develop resources to support clinicians delivering at-home palliative services to people who choose to be cared for and die at home. * Guidelines for handling palliative care medicines in community services * palliMEDS smartphone app to…

    1. NEW DRUGS Erenumab for migraine Monthly injections of erenumab can reduce the number of attacks in people who have frequent migraine. Find out more ► 2. MEDICINEWISE UPDATE  NOVEMBER 2018 caring@home is an Australian Government-funded project aiming to improve the quality of palliative care service delivery by developing a range of resources for community service providers,…

MEDICINEWISE UPDATE  OCTOBER 2018 1. Start of new CPD year The start of the new CPD year is already here. Get a head start on implementing your CPD plan now with our extensive range of free activities. Current topics include PPIs in GORD, plus statins, depression and COPD Start now 2. Webinar: Getting to the heart of…

Free webinar Thursday, 18 October 2018 7:00 – 8:00 pm AEDT  Register now A holistic approach to reducing CV risk in patients with type 2 diabetes & CVD Cardiovascular disease (CVD) is the leading cause of morbidity and mortality for people with diabetes and the largest contributor to the direct and indirect costs of diabetes.…

MEDICINEWISE UPDATE  SEPTEMBER 2018 1. Steve Morris welcomed as new NPS MedicineWise Chief Executive Officer It’s a funny thing taking over the leadership of an organisation that has been personally influential throughout one’s own career. When I first moved to Australia from the UK in 2009 I was already familiar with the then National Prescribing Service and an…

1. Taking medicines for gastro-oesophageal reflux disease (GORD)?  16 August 2018 Talk to your doctor about stepping down or stopping treatment Many Australians use proton pump inhibitors (PPIs)—such as omeprazole, esomeprazole and pantoprazole—to manage symptoms of gastro-oesophageal reflux disease (GORD), often for extended periods of time. Common brand names include Losec, Nexium, and Somac. Heartburn—which…

1. NEW DRUG Glecaprevir/pibrentasvir for hepatitis C This new combination is suitable for a wide range of patients with hepatitis C, but has the potential for many drug interactions. Find out more ►     2. MEDICINEWISE UPDATE      Announcing the launch of the latest Be Medicinewise Week campaign from NPS MedicineWiseBe Medicinewise Week 20-26 August…

MEDICINEWISE UPDATE  JULY 2018 Reviewing treatment for gastro-oesophageal reflux disease Complete this online case study to receive instant feedback on your responses and read expert commentary provided by Prof Geoff Hebbard, the Director of Gastroenterology and Hepatology at The Royal Melbourne Hospital. Start now Stepping the appropriate path with GORD medicines This Medicinewise News discusses…

MEDICINEWISE UPDATE JUNE  2018 Asthma webinar on-demand Watch our CPD-accredited webinar Difficult-to-treat and severe asthma: changing the paradigm to find out about new therapies, and how to identify and manage difficult-to-treat and severe asthma. Download replay ______________________________________ Neuropathic pain: current definition and review of drug treatment  The definition of neuropathic pain has changed and opioids…

 New Chief Executive for NPS MedicineWise Following an extensive search, the Board of NPS MedicineWise is delighted to announce the appointment of Mr Steve Morris as the new Chief Executive Officer of NPS MedicineWise. Since 2009, Mr Morris has held the position of Chief Pharmacist for South Australia and in 2012 was also appointed Executive Director of…